A new drug protocol for IVF ovarian hyperstimulation was developed
in Europe. It requires fewer injections and costs significantly
less than the standard protocol, making it far more patient
friendly. Futhermore, results with the new European protocol
have been comparable to those obtained with the current, standard
protocol. This protocol has been shown to be especially helpful
in patients who are low responders. However, it may be too strong
for very young patients or those who have polycystic ovarian
syndrome.
Currently, the standard protocol calls for the patient to
begin Lupron injections starting one week prior to the menstrual
period and to then add Gonadotropin injections to the Lupron
for a period of six to ten days until egg maturity occurs.
This standard protocol usually consists of a minimum of 21
injections and the use of approximately 25 to 35 ampoules
of Gonadotropin. The protocol typically costs between $2000
and $3000.
The new protocol combines the oral medication Clomid with
Gonadotropin injections given on alternate days. Instead of
receiving Lupron injections, the patient takes birth control
pills for three weeks prior to beginning treatment with Clomid
and Gonadotropin. The patient usually receives no more than
five injections of Gonadotropin during the course of stimulation.
In addition to fewer injections, the protocol requires much
less monitoring with sonograms and blood tests, which also
makes the patient's life easier. Our initial experience with
this protocol indicates that egg production as well as fertilization
rates and pregnancy rates are very similar to those seen when
using the standard treatment regimens.
The new European protocol costs significantly less than the
traditional IVF protocol. The Clomid costs no more than $100
and the Gonadotropin (16 to 20 ampoules) should cost a maximum
of $1200. Therefore, the European protocol may be a great
advantage for certain patients, especially those who are low
responders or who are prevented from having IVF treatment
because they are unable to afford the required medication.